Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in Bactrian camels

Journal of Integrative Agriculture

Volumn 16, Issue 10, 2017, Pages 2264-2273

  LIU, Ren qiang ^a   GE, Jin ying ^a   WANG, Jin ling ^b   SHAO, Yu ^a   ZHANG, Hui lei ^a   WANG, Jin liang ^a   WEN, Zhi yuan ^a   BU, Zhi gao ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

Author keywords

camels; MERS CoV; neutralizing antibodies; Newcastle disease virus

Indexed keywords

EID: 85037986914     PISSN: 20953119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2095-3119(17)61660-5     Document Type: Article

References (38)

1. OIE (World Organisation for Animal Health), OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 2004, Office International des Epizooties, Paris.
2. Annan, A, Baldwin, H J, Corman, V M, Klose, S M, Owusu, M, Nkrumah, E E, Badu, E K, Anti, P, Agbenyega, O, Meyer, B, Oppong, S, Sarkodie, Y A, Kalko, E K, Lina, P H, Godlevska, E V, Reusken, C, Seebens, A, Gloza-Rausch, F, Vallo, P, Tschapka, M, et al. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerging Infectious Diseases 19 (2013), 456–459.
3. Azhar, E I, El-Kafrawy, S A, Farraj, S A, Hassan, A M, Al-Saeed, M S, Hashem, A M, Madani, T A, Evidence for camel-to-human transmission of MERS coronavirus. The New England Journal of Medicine 370 (2014), 2499–2505.
4. Belouzard, S, Millet, J K, Licitra, B N, Whittaker, G R, Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4 (2012), 1011–1033.
5. Bukreyev, A, Collins, P L, Newcastle disease virus as a vaccine vector for humans. Current Opinion in Molecular Therapeutics 10 (2008), 46–55.
6. Bukreyev, A, Skiadopoulos, M H, Murphy, B R, Collins, P L, Nonsegmented negative-strand viruses as vaccine vectors. Journal of Virology 80 (2006), 10293–10306.
7. Chu, D K, Poon, L L, Gomaa, M M, Shehata, M M, Perera, R A, Abu Zeid, D, El Rifay, A S, Siu, L Y, Guan, Y, Webby, R J, Ali, M A, Peiris, M, Kayali, G, MERS coronaviruses in dromedary camels, Egypt. Emerging Infectious Diseases 20 (2014), 1049–1053.
8. Di Napoli, J M, Nayak, B, Yang, L, Finneyfrock, B W, Cook, A, Andersen, H, Torres-Velez, F, Murphy, B R, Samal, S K, Collins, P L, Bukreyev, A, Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. Journal of Virology 84 (2010), 1489–1503.
9. Di Napoli, J M, Yang, L, Samal, S K, Murphy, B R, Collins, P L, Bukreyev, A, Respiratory tract immunization of nonhuman primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine 29 (2010), 17–25.
10. Du, L, He, Y, Zhou, Y, Liu, S, Zheng, B J, Jiang, S, The spike protein of SARS-CoV – A target for vaccine and therapeutic development. Nature Review Microbiology 7 (2009), 226–236.
11. Enjuanes, L, Dediego, M L, Alvarez, E, Deming, D, Sheahan, T, Baric, R, Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Virus Research 133 (2008), 45–62.
12. Ge, J, Deng, G, Wen, Z, Tian, G, Wang, Y, Shi, J, Wang, X, Li, Y, Hu, S, Jiang, Y, Yang, C, Yu, K, Bu, Z, Chen, H, Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. Journal of Virology 81 (2007), 150–158.
13. Ge, J, Tian, G, Zeng, X, Jiang, Y, Chen, H, Bua, Z, Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine. Avian Diseases 54 (2010), 294–296.
14. Haagmans, B L, van den Brand, J M, Raj, V S, Volz, A, Wohlsein, P, Smits, S L, Schipper, D, Bestebroer, T M, Okba, N, Fux, R, Bensaid, A, Solanes Foz, D, Kuiken, T, Baumgartner, W, Segales, J, Sutter, G, Osterhaus, A D, An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science 351 (2016), 77–81.
15. Hofmann, H, Hattermann, K, Marzi, A, Gramberg, T, Geier, M, Krumbiegel, M, Kuate, S, Uberla, K, Niedrig, M, Pohlmann, S, S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. Journal of Virology 78 (2004), 6134–6142.
16. Khattar, S K, Collins, P L, Samal, S K, Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1. Vaccine 28 (2010), 3159–3170.
17. Kim, E, Okada, K, Kenniston, T, Raj, V S, AlHajri, M M, Farag, E A, AlHajri, F, Osterhaus, A D, Haagmans, B L, Gambotto, A, Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine 32 (2014), 5975–5982.
18. Kong, D, Wen, Z, Su, H, Ge, J, Chen, W, Wang, X, Wu, C, Yang, C, Chen, H, Bu, Z, Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology 432 (2012), 327–335.
19. Kortekaas, J, de Boer, S M, Kant, J, Vloet, R P, Antonis, A F, Moormann, R J, Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine 28 (2010), 4394–4401.
20. Li, Z, Jiang, Y, Jiao, P, Wang, A, Zhao, F, Tian, G, Wang, X, Yu, K, Bu, Z, Chen, H, The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. Journal of Virology 80 (2006), 11115–11123.
21. Liu, R, Wen, Z, Wang, J, Ge, J, Chen, H, Bu, Z, Absence of Middle East respiratory syndrome coronavirus in Bactrian camels in the West Inner Mongolia Autonomous Region of China: Surveillance study results from July 2015. Emerging Microbes & Infections, 4, 2015, e73.
22. Martinez-Sobrido, L, Gitiban, N, Fernandez-Sesma, A, Cros, J, Mertz, S E, Jewell, N A, Hammond, S, Flano, E, Durbin, R K, Garcia-Sastre, A, Durbin, J E, Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. Journal of Virology 80 (2006), 1130–1139.
23. Memish, Z A, Cotten, M, Meyer, B, Watson, S J, Alsahafi, A J, Al Rabeeah, A A, Corman, V M, Sieberg, A, Makhdoom, H Q, Assiri, A, Al Masri, M, Aldabbagh, S, Bosch, B J, Beer, M, Muller, M A, Kellam, P, Drosten, C, Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerging Infectious Diseases 20 (2014), 1012–1015.
24. Memish, Z A, Mishra, N, Olival, K J, Fagbo, S F, Kapoor, V, Epstein, J H, Alhakeem, R, Durosinloun, A, Al Asmari, M, Islam, A, Kapoor, A, Briese, T, Daszak, P, Al Rabeeah, A A, Lipkin, W I, Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerging Infectious Diseases 19 (2013), 1819–1823.
25. Millet, J K, Whittaker, G R, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proceedings of the National Academy of Sciences of the United States of America 111 (2014), 15214–15219.
26. Modjarrad, K, Moorthy, V S, Ben Embarek, P, Van Kerkhove, M, Kim, J, Kieny, M P, A roadmap for MERS-CoV research and product development: Report from a World Health Organization consultation. Nature Medicine 22 (2016), 701–705.
27. Muthumani, K, Falzarano, D, Reuschel, E L, Tingey, C, Flingai, S, Villarreal, D O, Wise, M, Patel, A, Izmirly, A, Aljuaid, A, A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Science Translational Medicine 7 (2015), 301–312.
28. Pascal, K E, Coleman, C M, Mujica, A O, Kamat, V, Badithe, A, Fairhurst, J, Hunt, C, Strein, J, Berrebi, A, Sisk, J M, Matthews, K L, Babb, R, Chen, G, Lai, K M, Huang, T T, Olson, W, Yancopoulos, G D, Stahl, N, Frieman, M B, Kyratsous, C A, Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America 112 (2015), 8738–8743.
29. Perera, R A, Wang, P, Gomaa, M R, El-Shesheny, R, Kandeil, A, Bagato, O, Siu, L Y, Shehata, M M, Kayed, A S, Moatasim, Y, Li, M, Poon, L L, Guan, Y, Webby, R J, Ali, M A, Peiris, J S, Kayali, G, Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Eurosurveillance, 18, 2013, 20574.
30. Sabir, J S, Lam, T T, Ahmed, M M, Li, L, Shen, Y, Abo-Aba, S E, Qureshi, M I, Abu-Zeid, M, Zhang, Y, Khiyami, M A, Alharbi, N S, Hajrah, N H, Sabir, M J, Mutwakil, M H, Kabli, S A, Alsulaimany, F A, Obaid, A Y, Zhou, B, Smith, D K, Holmes, E C, et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351 (2016), 81–84.
31. Song, F, Fux, R, Provacia, L B, Volz, A, Eickmann, M, Becker, S, Osterhaus, A D, Haagmans, B L, Sutter, G, Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. Journal of Virology 87 (2013), 11950–11954.
32. Wang, C, Zheng, X, Gai, W, Zhao, Y, Wang, H, Wang, H, Feng, N, Chi, H, Qiu, B, Li, N, MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques. Oncotarget 8 (2016), 12686–12694.
33. Wong, G, Liu, W, Liu, Y, Zhou, B, Bi, Y, Gao, G F, MERS, SARS, and ebola: The role of super-spreaders in infectious disease. Cell Host & Microbe 18 (2015), 398–401.
34. Wyatt, L S, Moss, B, Rozenblatt, S, Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210 (1995), 202–205.
35. Yeung, M L, Yao, Y, Jia, L, Chan, J F, Chan, K H, Cheung, K F, Chen, H, Poon, V K, Tsang, A K, To, K K, Yiu, M K, Teng, J L, Chu, H, Zhou, J, Zhang, Q, Deng, W, Lau, S K, Lau, J Y, Woo, P C, Chan, T M, et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nature Microbiology, 1, 2016, 16004.
36. Zhang, N, Channappanavar, R, Ma, C, Wang, L, Tang, J, Garron, T, Tao, X, Tasneem, S, Lu, L, Tseng, C T, Zhou, Y, Perlman, S, Jiang, S, Du, L, Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cellular & Molecular Immunology 13 (2016), 180–190.
37. Zhao, J, Li, K, Wohlford-Lenane, C, Agnihothram, S S, Fett, C, Zhao, J, Gale, M J Jr, Baric, R S, Enjuanes, L, Gallagher, T, McCray, P B Jr, Perlman, S, Rapid generation of a mouse model for Middle East respiratory syndrome. Proceedings of the National Academy of Sciences of the United States of America 111 (2014), 4970–4975.
38. Zumla, A, Chan, J F, Azhar, E I, Hui, D S, Yuen, K Y, Coronaviruses – Drug discovery and therapeutic options. Nature reviews. Drug Discovery 15 (2016), 327–347.